A Rare Opportunity With A Biotechnology ETF By: Benzinga via Benzinga March 17, 2016 at 07:54 AM EDT A frequent criticism of biotechnology stocks is that they usually trade at rich multiples, making the industry appear expensive not ... Read More >> Related Stocks: Amgen Biogen Idec Celgene Corp Gilead Sciences